Epidemiology and risk factors;Epidemiologie et facteurs de risque

Medecine et Maladies Infectieuses

Volumn 30, Issue SUPPL. 2, 2000, Pages 85-90

  Sedallian A ^a   Bland, S ^a  

^a Centre Hospitalier de la Region d'Annecy   (France)

Author keywords

Anaerobic infections; Normal flora; Virulence factors of anaerobes

Indexed keywords

VIRULENCE FACTOR;

ANAEROBIC INFECTION; BACTERIAL COLONIZATION; BACTERIAL FLORA; BACTERIAL VIRULENCE; BACTEROIDES FRAGILIS; FUSOBACTERIUM; HOST RESISTANCE; IMMUNE DEFICIENCY; PEPTOSTREPTOCOCCUS; PORPHYROMONAS; PREVOTELLA; REVIEW; RISK FACTOR;

EID: 0034162038     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Finegold SM. General aspects of anaerobic infections in anaerobic infections in humans. In: Finegold SM, George WL, eds. Anaerobic Infections in Humans. New York: Academic Press (USA); 1989. p. 147-55.
2. Sedallian A. Identification des anaérobies d'intérêt médical. Rev Fr Lab 1993; 255: 25-34.
3. Hentges DJ. Anaerobes as normal flora in anaerobic infections in humans. In: Finegold SM, George WL, eds. Anaerobic Infections in Humans. New York: Academic Press; 1989. p. 37-53.
4. Spiegel CA. Bacterial vaginosis. Clin Microbiol Rev 1991; 4: 485-502.
5. Finegold SM, Baron EJ, Wexler HM. A clinical guide to anaerobic infections. In: Tester HJR, ed. Clinical Guide to Anaerobic Infection, Wadsworth Anaerobe Laboratory. Belmont, CA: Star Publishing Company; 1992. p. 17-91.
6. Bjorson A. Host defense mechanisms against non-spore forming anaerobic bacteria. In: Finegold SM, George WL, eds. Anaerobic Infections in Humans. New York: Academic Press; 1989. p. 97-110.
7. Sebald M. Déterminants de la pathogénicité de Bacteroides fragilis. Med Mal Infect 1996; 26: 185-91.
8. Tang YP, Dallas MM, Malamy MH. Studies on bacteroides mutants with altered aerotolerance. 2nd World Congress on Anaerobic Bacteria. Nice France, October 1998. Abstract n° 1002.
9. Brook I, Myhal L. Adherence of Bacteroides fragilis group. Infect Immun 1991; 59: 742-4.
10. Pantosi A, Tzianabos O, Onderdonck A, Kasper DL. Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis. Infect Immun 1991; 59: 2075-82.
11. Onderdonk AB, Cisneros RL, Bartlett JG. The capsular polysaccharide as a virulence factor. J Infect Dis 1997; 136: 82-9.
12. Tzianabos O, Kasper DL, Cisneros RL, Onderdonck A. Polysaccharide mediated protection against abscess formation associated with intraabdominal sepsis. World Congress on Anaerobic Bacteria and Infection Puerto-Rico, November 1995. Abstract n° 2.
13. Tzianabos AO, Onderdonk AB, Finberg RW, Chan M, Wang Y, Kasper DL. T cell activation by zwitterionic polysaccharides and peptides mimetics prevents intra-abdominal abscess formation. 2nd World Congress on Anaerobic Bacteria, Nice France, October 1998. Abstract n° 4003.
14. Sears CL. The toxins of Bacteroides fragilis. A story in evolution. 2nd World Congress on Anaerobic Bacteria, Nice France, October 1998. Abstract n° 1005.
15. Zhang G, Weintraub A. Rapid and sensitive assay for detection of enterotoxigenic Bacteroides fragilis. J Clin Microbiol 1998; 36: 3545-8.
16. Sebald M. Fusobacterium. In: Le Minor L, Véron M, eds. Bactériologie Médicale. Paris: Flammarion: 1989. p. 744-9.
17. Shinjo T, Fujisawa T, Mitsuoka T. Proposal of two subspecies of Fusobacterium necrophorum (Pflügge) Moore and Holdeman: Fusobacterium necrophorum subsp. Necrophorum subsp. nov., nom rev. (Flugge 1886) Fusobacterium subsp. fundiliforme subsp. nov., nom.rev. (Halle 1989). Int J Syst Bacteriol 1997; 47: 395-7.
18. Amoako KK, Goto Y, Shinjo T. Comparison of extracellular enzymes of Fusobacterium necrophorum subsp necrophorum and Fusobacterium necrophorum subsp fundiliforme. J Clin Microbiol 1993; 31: 2244-7.
19. Nagaraja TG, Sun Y, Saats J, Chengappa MM. Leucotoxin of Fusobacterium necrophorum quantification, immunity and role in protection. 2nd World Congress on Anaerobic Bacteria, Nice France, October 1998. Abstract n° 2004.
20. Grenier D, Mayraud D. Selected characteristics of pathogenic and non pathogenic strains of Bacteroides gingivalis. J Clin Microbiol 1987; 25: 738-40.
21. Jonsimies-Somer H. Recently described clinically important anaerobic bacteria: Taxonomic aspects and update. Clin Infect Dis 1997; 25 Suppl 2: 78-88.
22. Shah HN, Collins HD. Proposal for reclassification of Bacteroïdes asaccharolyticus, Bacteroides gingivalis and Bacteroïdes endodontalis in a new genus Porphyromonas. Int J Syst Bacteriol 1988; 38: 128-31.
23. Njoroje T, Hamada N, Genco RJ, Fajar HT. Genco CA. A role for fimbriae in Porphyromonas gingivalis invassion of oral epithelium. Infect Immun 1997; 65: 1980-4.
24. Krepel CJ, Gorh CM. Edmiston CE, Farmer SG. Anaerobic pathogenesis: Collagenase production by Peptostreptococcus magnus and its relationship to site of infection. J Infect Dis 1991; 163: 1148-50.
25. Felten A, Desplaces N, Nizard R, Sedel L, Lagrange PH. Infetions à Peptostreptococcus magnus après intervention orthopédique. Identification, sensibilité aux antibiotiques, adhésion aux protéines de la matrice extracellulaire. Path Biol 1998; 46: 442-8.
26. Sebald M. Clostridium. In: Le Minor L, Veron M. éd. Bacteriologie Médicale. Paris: Flammarion; 1989. p. 887-931.
27. Titball RW, Naylor CE, Basak AK. The Clostridium perfringens toxin. Anaerobe 1999; 5: 51-65.
28. Prévot AR. Manuel de classification et de détermination des bactéries anaérobics. Monographie de l'Institut Pasteur. Paris: Masson; 1940.
29. Beerens H, Tahon-Castel M. Infections Humaines à Bactéries Anaérobies non Toxinogènes. Bruxelles: Presses Académiques Européennes; 1965.